Copyright © BioBAT, Inc. All rights reserved.
IRX Therapeutics, Inc.
IRX Therapeutics is a clinical-stage bioresearch company developing IRX-2, an important new immunotherapy candidate for cancer. IRX Therapeutics is developing novel immunotherapies based upon reversing immune suppression that is typically seen in patients with cancer and other diseases. The lead product, IRX-2, is a primary cell-derived biologic with multiple active cytokine components that acts on multiple cell types of the immune system including T cells, dendritic cells, and natural killer cells.
Avatar is a private biotechnology company applying proprietary technologies to develop conformationally locked, improved subunit vaccine immunogens. The company’s technologies enhance the performance of these products by stabilizing their conformations, which then better represent the 3-D structure of these proteins on the surface of the pathogen, and therefore give rise to more protective antibody responses. Avatar is collaborating with several organizations to develop products and technologies in this space, including the Vaccine Research Center/NIAID, the Laboratory of Infectious Diseases/NIAID, Dartmouth College, the Vanderbilt Vaccine Center, Rutgers University, and Duke University.
International AIDS Vaccine Initiative (IAVI)
IAVI's AIDS Vaccine Design and Development Laboratory is a versatile facility designed for conducting biological research on novel vaccines. Ongoing work encompasses multiple phases of vaccine development including generation of new vaccines, assessment of vaccine candidates, and generation of supporting technologies needed to advance the most promising candidates to the stage where they can be evaluated in clinical trials. The Lab also collaborates with multiple academic and industry partners to help advance new AIDS vaccine candidates and perform research needed to better understand how the immune system responds to HIV infection or immunization with experimental vaccines.
Modern Meadow, Inc.
Modern Meadow develops cultured animal products including leather, food and other applications without the need for harming animals or the environment. By leveraging the latest advances in biotechnology and bio fabrication, the Company is able to make better materials and animal products with demonstrated advantages for design, performance, manufacturing and sustainability.